P&T
Our
Other
Journal
MediMedia Managed Markets

 

Assessing Clinical Outcomes and Cost: Transforming Dyslipidemia Management

Assessing Clinical Outcomes and Cost: Transforming Dyslipidemia Management

This is the second of two reports from the 2003 Medical Director Colloquy, which focused on care and management of patients with dyslipidemia. This supplement includes discussions of new technological tools to optimize care delivery, efficient methods of identifying high-risk patients, and recent advances in the diagnostic arena. It also provides a range of perspectives from an expert faculty on underdiagnosis and undertreatment of dyslipidemia. This meeting yielded novel concepts to balance outcomes and costs of dyslipidemia management.

Highlights:

  • New Insights Into the Nature of Coronary Artery Disease: The Inside View
  • Obtaining Optimal Compliance With Drug Therapy
  • Improving Outcomes and Reducing Cost: The Role of Predictive Modeling
  • The Quality of Health Care: An Employer’s Perspective